Drug Approved for Advanced Kidney Cancer (HealthDay)
HealthDay – FRIDAY, Jan. 27 (HealthDay News) — Inlyta (axitinib) has been approved by the U.S. Food and Drug Administration to treat advanced renal cell carcinoma in people who haven’t responded to another drug.
Read the original:
Drug Approved for Advanced Kidney Cancer
(HealthDay)
Obama lawyers argue rest of health law can survive
WASHINGTON (Reuters) – The Obama administration told the Supreme Court on Friday that nearly all of President Barack Obama’s healthcare overhaul can survive if the court declares unconstitutional the law’s centerpiece provision requiring health coverage.
Originally posted here:
Obama lawyers argue rest of health law can survive
US FDA approves Pfizer’s Inlyta for kidney cancer (Reuters)
Reuters – Pfizer’s Inlyta drug for patients with advanced kidney cancer won approval from U.S.
Read more here:
US FDA approves Pfizer’s Inlyta for kidney cancer
(Reuters)
Avastin’s Failure in Breast Cancer: New Study May Explain Why It Happened (LiveScience.com)
LiveScience.com – A new study may explain why the cancer drug Avastin hasn’t worked in the treatment of breast cancer patients. Although the drug stops tumor growth for a short time, it often leads to more invasive tumors in the long run.
See the original post:
Avastin’s Failure in Breast Cancer: New Study May Explain Why It Happened
(LiveScience.com)
Test Might Predict Risk of Lung Cancer’s Return (HealthDay)
HealthDay – THURSDAY, Jan.
See more here:
Test Might Predict Risk of Lung Cancer’s Return
(HealthDay)
Statins May Stave Off Liver Cancer in People With Hepatitis B (HealthDay)
HealthDay – THURSDAY, Jan. 26 (HealthDay News) — Popular cholesterol-lowering statins may also lower risk for liver cancer among people with hepatitis B, a new study shows. Hepatitis B, an inflammation of the liver due to the hepatitis B virus, is one of the main causes of liver cancer.
Excerpt from:
Statins May Stave Off Liver Cancer in People With Hepatitis
B
(HealthDay)
Infinity stops cancer trial as drug fails to show (Reuters)
Reuters – Infinity Pharmaceuticals said it stopped a mid-stage trial of its experimental pancreatic cancer drug following an interim analysis that showed it would not meet its main goal.
Read more:
Infinity stops cancer trial as drug fails to show
(Reuters)
China cadmium spill threatens drinking water for millions
BEIJING (Reuters) – A cancer-causing cadmium discharge from a mining company has polluted a long stretch of two rivers in southern China, and officials warned some 3.7 million people of Liuzhou in the Guangxi region to avoid drinking water from the river, state media reported on Friday.
Visit link:
China cadmium spill threatens drinking water for millions
French breast implant boss arrested
MARSEILLE, France (Reuters) – Jean-Claude Mas, the Frenchman who sparked a global health scare by selling substandard breast implants, was arrested on Thursday as Marseille prosecutors build a case against him for manslaughter.
View original post here:
French breast implant boss arrested
Too Few Americans Getting Screened for Common Cancers: CDC (HealthDay)
HealthDay – THURSDAY, Jan. 26 (HealthDay News) — The number of Americans being screened for colon, breast and cervical cancers still fall below national targets, federal health officials said Thursday.
Follow this link:
Too Few Americans Getting Screened for Common Cancers: CDC
(HealthDay)
Share your thoughts..